Table of Contents
What changed
Group operating revenue rose 33.3% to $1,715.3m, but the earnings line reversed sharply: PBT moved from a $1,274.7m profit to a $128.6m loss, and NPAT swung from $1,174.9m to a $212.2m loss. The prior comparable period benefited from very large non-trading gains (HY24 continuing-operations profit grew 450% on the release excerpts); those gains are absent in HY25, which accounts for almost the entire year-on-year earnings swing. Operating cash flow fell 44.1% to $93.1m while capex rose to $207.9m from $165.1m, so pre-lease free cash flow turned negative at –$114.8m (HY24: +$1.3m). Against that, cash ballooned to $496.3m from $146.5m, gross borrowings eased 4.3% to $5,136.3m, and the interim dividend was lifted 3.6% to 7.25 cps.
What matters
- Underlying trading is softer than the revenue line suggests. Stripping out the prior-year gains, the segment result is weak: One NZ contributed 54.8% of revenue but posted a $50.0m segment loss (vs –$0.5m), Manawa Energy flipped from a $55.9m profit to a $3.3m loss despite revenue growth, and Qscan's profit contribution halved to $9.1m on lower revenue. Associates ($107.0m) and RHCNZ Medical Imaging ($11.1m) were the main positive contributors.
- Cash quality deteriorated sharply. OCF fell to 56% of the prior-period level while capex rose ~26%, producing a $116m negative swing in pre-lease FCF. Capex intensity remained broadly steady at ~12% of revenue, so the deterioration is driven by the operating leg, not spending discipline.
- Balance-sheet direction is the bright spot. Estimated net debt fell to ~$4.64b from ~$5.22b, equity rose to $8,188.6m, and cash is 3.4x the prior-period level, giving Infratil materially more flexibility to fund the growth pipeline it refers to qualitatively.
Expectations
No quantitative FY25 revenue, EBITDAF or forward-work targets were disclosed in the extracted release. Last year's FY24 update lifted proportionate EBITDAF guidance to $820–$850m, but no comparable HY25 EBITDAF figure has been supplied in the extract, so guidance tracking cannot be tested. On shape, HY24 contributed only ~42.9% of FY24 revenue, indicating a second-half skew; annualised HY25 revenue of $3,430.6m is already 14.5% above FY24's $2,995.2m, consistent with continued top-line growth if the usual H2 weighting holds. The earnings shape is not informative because FY24 NPAT ($845.1m) was itself below HY24 NPAT, reflecting the one-off-heavy first half.
Quality of result
Much of the reported variance is not underlying. The NPAT collapse is dominated by the absence of the prior-period non-trading gain rather than a step-down in continuing operations, so PBT is the cleaner read — and it too is in loss. The tax line distorts the picture further: a $77.8m tax expense on a $128.6m pre-tax loss produces a –60.5% effective rate, widening the headline NPAT loss relative to PBT. What is durable and negative is the segment-level weakness (One NZ, Manawa) and the deterioration in cash conversion. What is durable and positive is the lower gross debt, higher cash, and lifted dividend, which suggest board confidence in the forward cash profile despite the negative HY25 pre-lease FCF.
Unresolved
- Why did Manawa Energy swing from a $55.9m profit to a loss on higher revenue, and is the One NZ $50m segment loss a step-change or an investment-phase outcome?
- What is the current-period proportionate EBITDAF, and does it track the FY24 $820–$850m guidance trajectory?
- What drove the $73m decline in operating cash flow — working capital, interest, or underlying trading — given the limited working-capital disclosure in the extract?
- What explains the $186m gross cash proceeds reference in the release, and is a further disposal-related contribution expected in H2?
- How is the $496.3m cash balance earmarked against the CDC, Gurīn Energy and other growth pipelines?
This briefing cannot assess segment-level EBITDAF, proportionate earnings, or valuation multiples, because neither a current-period EBITDAF figure nor NTA per share was provided in the extracted data.
Key metrics
| Metric | HY25 | HY24 | Change |
|---|---|---|---|
| Revenue | $1715.3m | $1286.6m | +33.3% ↑ |
| EBITDA | — | $400m | — |
| Net profit after tax | −$212.2m | $1174.9m | -118.1% ↓ |
| Net cash inflow from operating activities | $93.1m | $166.4m | -44.1% ↓ |
| Interim dividend per share | 7.2c | 7.0c | +3.6% ↑ |
| Operating profit | $136.4m | $301.7m | -54.8% ↓ |
| Profit before tax | −$128.6m | $1274.7m | -110.1% ↓ |
| Cash and cash equivalents | $496.3m | $146.5m | +238.8% ↑ |
| Total assets | $16092.6m | $15979.3m | +0.7% ↑ |
Reference: annolyse.ai/briefings/ift-hy25
Segment breakdown
| Segment | Current revenue | Prior revenue | Current result | Mix shift |
|---|---|---|---|---|
| Gurīn Energy | −$0.3m | $0.3m | −$14.6m | 0.0pp |
| Manawa Energy | $305.2m | $217.8m | −$3.3m | +0.9pp |
| Mint Renewables | $0m | $0m | −$5.8m | +0.0pp |
| One NZ | $939.6m | $650.9m | −$50m | +4.2pp |
| Qscan Group | $176m | $329.9m | $9.1m | -15.4pp |
| RHCNZ Medical Imaging | $190.7m | — | $11.1m | n/a |
| Wellington Airport | $90.9m | $76.7m | −$0.8m | -0.7pp |
| Associates | — | — | $107m | n/a |
| All other segments and corporate | $0.2m | $92.8m | −$39.3m | -7.2pp |
Reference: annolyse.ai/briefings/ift-hy25
Analytical metrics
| Metric | HY25 | HY24 | Context |
|---|---|---|---|
| Effective tax rate | n/m (loss period) | 4.7% | current loss period |
| FCF pre-lease | −$114.8m | $1.3m | −$116.1m |
| FCF / NPAT | 54.1% | 0.1% | complementary conversion metric |
| Capex % revenue | 12.1% | 12.8% | — |
| Capex | −$207.9m | $165.1m | −$373.0m |
| Net debt | $4640.0m | $5222.7m | −$582.7m |
| Gross borrowings | $5136.3m | $5369.2m | −$232.9m |
| ROE (annualised) | -2.6% | 14.7% | Weakening |
| HY24 share of FY24 revenue | 42.9% | — | Other half was 57.1% |
| HY24 share of FY24 NPAT | 139.1% | — | Other half was -39.1% |
| Profit from continuing operations | −$206.4m | $1215.1m | −$1421.5m |
| Discontinued operation after tax | $0.0m | −$0.6m | +$0.6m |
Reference: annolyse.ai/briefings/ift-hy25
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX/ASX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.